Exponent (NASDAQ: EXPO) and Huron Consulting Group (NASDAQ:HURN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.
Earnings & Valuation
This table compares Exponent and Huron Consulting Group’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Exponent||$315.08 million||5.86||$47.48 million||$2.05||34.90|
|Huron Consulting Group||$797.98 million||1.06||$37.61 million||($6.35)||-5.99|
Exponent has higher revenue, but lower earnings than Huron Consulting Group. Huron Consulting Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
88.6% of Exponent shares are owned by institutional investors. Comparatively, 88.0% of Huron Consulting Group shares are owned by institutional investors. 2.8% of Exponent shares are owned by company insiders. Comparatively, 2.7% of Huron Consulting Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This is a summary of recent ratings and price targets for Exponent and Huron Consulting Group, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Huron Consulting Group||0||2||3||0||2.60|
Exponent presently has a consensus price target of $79.50, suggesting a potential upside of 11.11%. Huron Consulting Group has a consensus price target of $48.00, suggesting a potential upside of 26.15%. Given Huron Consulting Group’s stronger consensus rating and higher probable upside, analysts plainly believe Huron Consulting Group is more favorable than Exponent.
Risk and Volatility
Exponent has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, Huron Consulting Group has a beta of 0.06, suggesting that its share price is 94% less volatile than the S&P 500.
This table compares Exponent and Huron Consulting Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Huron Consulting Group||-17.09%||7.50%||3.83%|
Exponent pays an annual dividend of $0.84 per share and has a dividend yield of 1.2%. Huron Consulting Group does not pay a dividend. Exponent pays out 41.0% of its earnings in the form of a dividend.
Exponent beats Huron Consulting Group on 11 of the 16 factors compared between the two stocks.
Exponent, Inc. (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Exponent serves clients in automotive, government, health, insurance, manufacturing and technology, among others.
About Huron Consulting Group
Huron Consulting Group Inc. is a global professional services firm. The Company offers solutions in operations, advisory services, technology and analytics for healthcare, higher education, life sciences and commercial sectors. The Company’s segments include Healthcare, Education and Life Sciences, and Business Advisory. Its Healthcare segment provides advisory services, from strategy setting through implementation, in the areas of organizational and resource alignment, clinical transformation, financial and operational performance, patient and caregiver engagement, and technology implementation and optimization. Its Education and Life Sciences segment provides management consulting and technology solutions to the higher education and academic medical centers, pharmaceutical and medical device, biotechnology and research industries. The Business Advisory segment’s primary service lines include Enterprise Solutions and Analytics, and Business Advisory.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.